Two-stage nanoparticle delivery of piperlongumine and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) anti-cancer therapy. [electronic resource]
Publication details: Technology Mar 2016Description: 60-69 p. digitalISSN:- 2339-5478
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.